1. |
Hasegawa S, Yoshikawa T. Adenocarcinoma of the esophagogastric junction: incidence, characteristics, and treatment strategies. Gastric cancer, 2010, 13(2): 63-73.
|
2. |
Ielpo B, Pernaute AS, Elia S, et al. Impact of number and site of lymph node invasion on survival of adenocarcinoma of esophago-gastric junction. Interact Cardiovasc Thorac Surg, 2010, 10(5): 704-708.
|
3. |
Siewert JR, Holscher AH, Becker K, et al. Cardia cancer: attempt at a therapeutically relevant classification . Chirurg, 1987, 58(1): 25-32.
|
4. |
Mariette C, Piessen G, Briez N, et al. Oesophagogastric junction adenocarcinoma: which therapeutic approach? Lancet Oncol, 2011, 12(3): 296-305.
|
5. |
Siewert JR, Feith M, Stein HJ. Biologic and clinical variations of adenocarcinoma at the esophago-gastric junction: relevance of a topographic-anatomic subclassification. J Surg Oncol, 2005, 90(3): 139-146.
|
6. |
Sasako M, Sano T, Yamamoto S, et al. Left thoracoabdominal approach versus abdominal-transhiatal approach for gastric cancer of the cardia or subcardia: a randomised controlled trial. Lancet Oncol, 2006, 7(8): 644-651.
|
7. |
Goto H, Tokunaga M, Miki Y, et al. The optimal extent of lymph node dissection for adenocarcinoma of the esophagogastric junction differs between Siewert type Ⅱ and Siewert type Ⅲ patients. Gastric Cancer, 2015, 18(2): 375-381.
|
8. |
Casson AG, Rusch VW, Ginsberg RJ, et al. Lymph node mapping of esophageal cancer. Ann Thorac Surg, 1994, 58(5): 1569-1570.
|
9. |
Takubo K, Makuuchi H, Fujita H, et al. Japanese classification of esophageal cancer, tenth edition: part I. Esophagus, 2009, 6(1): 1-25.
|
10. |
Zhang H, Wang W, Cheng Y, et al. Adenocarcinomas of the esophagogastric junction: experiences at a single institution in China . World J Surg Oncol, 2013, 11: 155.
|
11. |
Hosokawa Y, Kinoshita T, Konishi M, et al. Clinicopathological features and prognostic factors of adenocarcinoma of the esophago-gastric junction according to Siewert classification: experiences at a single institution in Japan. Ann Surg Oncol, 2012, 19(2): 677-683.
|
12. |
李守淼, 李子禹, 季鑫. SiewertⅡ型胃食管结合部腺癌淋巴结转移的特点. 中华肿瘤杂志, 2013, 35(4): 288-291.
|
13. |
Yamashita H, Katai H, Morita S, et al. Optimal extent of lymph node dissection for Siewert type Ⅱ esophagogastric junction carcinoma . Ann Surg, 2011, 254(2): 274-280.
|
14. |
Goto H, Tokunaga M, Miki Y, et al. The optimal extent of lymph node dissection for adenocarcinoma of the esophagogastric junction differs between Siewert type Ⅱ and Siewert type Ⅲ patients. Gastric cancer, 2014, [Epub ahead of print].
|
15. |
Pedrazzani C, De manzoni G, Marrelli D, et al. Lymph node involve-ment in advanced gastroesophageal junction adenocarcinoma . J Thorac Cardiovasc Surg, 2007, 134(2): 378-385.
|
16. |
陈希, 胡祥, 曹亮. Siewert Ⅱ型和Ⅲ型食管胃结合部腺癌的淋巴结转移规律. 中华消化外科杂志, 2014, 13(2): 115-119.
|
17. |
刘巍, 郝希山, 陈勇, 等. 1526例胸段食管癌及贲门癌淋巴结转移状况分析(附1996~2004年河北医科大学第四医院随机抽样报告) . 中国肿瘤临床, 2008, 35(11): 601-605.
|
18. |
Rüdiger Siewert J, Feith M, Werner M, et al. Adenocarcinoma of the esophagogastric junction: results of surgical therapy based on anatomical/topographic classification in 1,002 consecutive patients. Ann Surg, 2000, 232(3): 353-361.
|
19. |
周金哲, 周岩冰, 沈毅, 等. Siewert Ⅱ型和Ⅲ型食管胃结合部腺癌经胸与经腹食管裂孔手术的疗效比较. 中华消化外科杂志, 2014, 13(2): 105-109.
|
20. |
Feith M, Stein HJ, Siewert JR. Adenocarcinoma of the esophagogas-tric junction: surgical therapy based on 1602 consecutive resected patients. Surg Oncol Clin N Am, 2006, 15(4): 751-764.
|
21. |
Ito H, Inoue H, Odaka N, et al. Clinicopathological characteristics and optimal management for esophagogastric junctional cancer; a single center retrospective cohort study. J Exp Clin Cancer Res, 2013, 32: 2.
|
22. |
Wolff CS, Castillo SF, Larson DR, et al. Ivor Lewis approach is superior to transhiatal approach in retrieval of lymph nodes at esophagectomy. Dis Esophagus, 2008, 21(4): 328-333.
|
23. |
Barbour AP, Rizk NP, Gonen M, et al. Adenocarcinoma of the gastroesophageal junction: influence of esophageal resection margin and operative approach on outcome . Ann Surg, 2007, 246(1): 1-8.
|